Ocera Therapeutics
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| AST-120 Used to Treat Mild Hepatic Encephalopathy (NCT00867698) | Ocera Therapeutics | 2009-03-01 |
| Safety and Efficacy of AST-120 in Patients With GERD Who Continue to be Symptomatic on a Standard Dose of PPI (NCT00587275) | Ocera Therapeutics | 2007-10-01 |
| Safety and Efficacy of AST-120 Compared to Lactulose in Patients With Hepatic Encephalopathy (NCT00558038) | Ocera Therapeutics | 2007-09-01 |
| Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome (NCT00583128) | Ocera Therapeutics | 2007-08-01 |
| Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis (NCT00583531) | Ocera Therapeutics | 2007-03-01 |
| Safety and Efficacy of AST-120 in the Treatment of Pouchitis (NCT00583076) | Ocera Therapeutics | 2007-02-01 |
| Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas (NCT00321412) | Ocera Therapeutics | 2006-03-01 |
Track Ocera Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.